These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 10393603
1. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. Hunt A, Joel S, Dick G, Goldman A. J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603 [Abstract] [Full Text] [Related]
2. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Quigley C, Joel S, Patel N, Baksh A, Slevin M. Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850 [Abstract] [Full Text] [Related]
3. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories. Du X, Skopp G, Aderjan R. Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341 [Abstract] [Full Text] [Related]
4. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Klepstad P, Dale O, Kaasa S, Zahlsen K, Aamo T, Fayers P, Borchgrevink PC. Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591 [Abstract] [Full Text] [Related]
5. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain. De Gregori S, Minella CE, De Gregori M, Tinelli C, Ranzani GN, Govoni S, Allegri M, Regazzi M. Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069 [Abstract] [Full Text] [Related]
13. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat. Van Crugten JT, Somogyi AA, Nation RL, Reynolds G. Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481 [Abstract] [Full Text] [Related]
14. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients. Oosten AW, Abrantes JA, Jönsson S, Matic M, van Schaik RHN, de Bruijn P, van der Rijt CCD, Mathijssen RHJ. Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868 [Abstract] [Full Text] [Related]
15. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Klepstad P, Kaasa S, Borchgrevink PC. Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448 [Abstract] [Full Text] [Related]
16. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain. Goucke RC, Hackett PL, Ilett KF. Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404 [Abstract] [Full Text] [Related]
17. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH. Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170 [Abstract] [Full Text] [Related]